Loading clinical trials...
Loading clinical trials...
Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by pancreatic beta cells destruction, resulting in insulin secretion deficit (1). Insulin therapy is essential in the therapeutic...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
NCT07222137 · Diabetes Mellitus, Type 1
NCT06807190 · Diabetes Mellitus, Type 1
NCT07160816 · Diabetes Mellitus, Type 1
NCT04786262 · Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness, and more
NCT07478211 · Diabetes Mellitus, Type 1, Energy Metabolism
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions